Articles

Efficacy and safety assessment of prolonged maintenance with subcutaneous rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: results of the Phase III MabCute study

Derriford Hospital and Plymouth University Medical School, Plymouth, United Kingdom
Hemocentro Ribeirão Preto, University of São Paulo, São Paulo, Brazil
Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
IRCCS AOU San Martino-IST, Genova, Italy
Centre Hospitalier Universitaire François Mitterand, Dijon, France
Kent and Canterbury Hospital, Canterbury, United Kingdom
Munich Clinic Schwabing, Academic Teaching Hospital, Ludwig-Maximilians University, Munich, Germany
DSM, University of Trieste, Trieste, Italy
F. Hoffmann-La Roche Ltd, Basel, Switzerland
F. Hoffmann-La Roche Ltd, Basel, Switzerland
F. Hoffmann-La Roche Ltd, Basel, Switzerland
F. Hoffmann-La Roche Ltd, Basel, Switzerland
Klinikum der Universität München, Munich, Germany
Haematologica Early view Jun 17, 2021 https://doi.org/10.3324/haematol.2020.274803